![](/img/cover-not-exists.png)
Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval
Pascart, Tristan, Norberciak, Laurène, Ea, Hang-Korng, Graf, Sahara, Guggenbuhl, Pascal, Lioté, FrédéricLanguage:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/kez203
Date:
June, 2019
File:
PDF, 392 KB
english, 2019